GENOMIC VALLEY BIOTECH LTD Q2 RESULTS
![Biocon Q1 Results: Net Jumps 6-fold to Rs 660 cr on one-time gain](https://img.etimg.com/thumb/msid-112392222,width-100,height-75,resizemode-4/markets/stocks/earnings/biocon-q1-results-net-jumps-6-fold-to-rs-660-cr-on-one-time-gain.jpg)
Biocon Q1 Results: Net Jumps 6-fold to Rs 660 cr on one-time gain
Biocon's net profit for Q1FY25 surged to ₹660 crore, up from ₹101 crore the previous year, primarily due to a one-time gain from selling Biocon Biologics' domestic branded formulation business. Revenue remained flat at ₹3,433 crore. Core EBITDA saw a decline, although overall EBITDA improved significantly due to the one-off gain.
![Syngene Q1 Results: Net profit drops 19% to Rs 76 crore](https://img.etimg.com/thumb/msid-111989167,width-100,height-75,resizemode-4/markets/stocks/earnings/syngene-q1-results-net-profit-drops-19-to-rs-76-crore.jpg)
Syngene Q1 Results: Net profit drops 19% to Rs 76 crore
Syngene International, the contract research and manufacturing services arm of Biocon, reported 19% year-on-year (YoY) drop in net profit to Rs.76 crore in Q1FY25 led by discovery services revenue taking a hit due to funding constraints at US biotechs.
![Amazon’s q-comm move; green shoots for IT sector](https://img.etimg.com/thumb/msid-111913079,width-100,height-75,resizemode-4/tech/newsletters/morning-dispatch/amazons-q-comm-move-green-shoots-for-it-sector.jpg)
Amazon’s q-comm move; green shoots for IT sector
Happy Monday! Amazon wants to catch up in the quick commerce race. We have a Monday AM scoop on the latest from the US ecommerce major in today's ETtech Morning Dispatch.
![Ajanta Pharma buyback: Last day today to buy shares for Rs 285 crore special situation opportunity](https://img.etimg.com/thumb/msid-110527020,width-100,height-75,resizemode-4/markets/stocks/news/ajanta-pharma-buyback-last-day-today-to-buy-shares-for-rs-285-crore-special-situation-opportunity.jpg)
Ajanta Pharma buyback: Last day today to buy shares for Rs 285 crore special situation opportunity
Ajanta Pharma has set May 30 as the record date for its Rs 285 crore share buyback,. The buyback, at a premium of 12.6%, targets 10,28,881 equity shares, constituting 8.34% of the company's aggregate equity. Amidst strong financials, the company reported a 66% YoY growth in PAT and a 20% YoY increase in revenue in its Q4 results.
![Q4 results today: ITC, IndiGo among 181 companies to announce earnings on Thursday](https://img.etimg.com/thumb/msid-110348712,width-100,height-75,resizemode-4/markets/stocks/earnings/q4-results-today-itc-indigo-among-181-companies-to-announce-earnings-on-thursday.jpg)
Q4 results today: ITC, IndiGo among 181 companies to announce earnings on Thursday
181 companies, including IndiGo and ITC, will announce their quarterly earnings for Jan-Mar 2024. IndiGo is expected to post healthy earnings, while ITC may see muted revenue growth.
![Responsible Innovation, how a blueprint for collaborative action is advancing global healthcare](https://img.etimg.com/thumb/msid-110275238,width-100,height-75,resizemode-4/industry/healthcare/biotech/healthcare/responsible-innovation-how-a-blueprint-for-collaborative-action-is-advancing-global-healthcare.jpg)
Responsible Innovation, how a blueprint for collaborative action is advancing global healthcare
On the occasion of the Abu Dhabi Global Healthcare Week (ADGHW), Dr. Asma Ibrahim Al Mannaei, Executive Director of the Research and Innovation Centre, discusses the UAE's prioritisation of healthcare in driving investments and partnerships focusing on advancing technology and attracting top talent and fostering collaboration with India reflecting shared challenges and opportunities in healthcare. Overall, collaboration with global partners and investment in manufacturing capabilities exemplify the UAE's commitment to healthcare excellence and innovation, while initiatives like Malaffi enhance data-driven services. Read on to discover how ADGHW aims to faciliate responsible innovation in healthcare, even as the UAE emphasises patient rights protection in an era of advancing AI and data usage.
- Go To Page 1
Empowering healthcare innovations: Dr. Noura Khamis Al Ghaithi on ADGHW's role in global healthcare collaboration
H.E. Dr. Noura Khamis Al Ghaithi discusses ADGHW as a platform for global healthcare collaboration, focusing on innovations and partnerships with Indian healthcare providers. The event aims to develop precision health initiatives, strengthen life sciences research, attract medical tourism, and support a growing startup ecosystem.
Piramal Pharma shares soar 11%, hit 52-week high after Q4 profit jumps 102% YoY
The company's revenue from operations increased by 18% to Rs 2,552.4 crore as against Rs 2,163.6 crore in the corresponding period of the preceding fiscal.
TCS Q4 net profit up 9%; two partners leave Lightspeed
Revenue from operations saw a marginal 3.5% year-on-year increase to Rs 61,327 crore. In constant currency terms, TCS clocked a revenue growth of 2.2% in the March quarter. The growth was led by the India business (up 38%), followed by the UK (6.2%).
Hyderabad’s proposed elevated corridor to boost entrepreneurial ecosystem and promote development
Hyderabad's proposed elevated corridor will revolutionize connectivity, infrastructure, and development in Genome Valley, benefitting life sciences companies. The corridor is a strategic move to propel Hyderabad as a leading life sciences hub, attracting investments and fostering innovation in the sector.
Q3 results today: Zomato, LIC, Grasim among 270 companies to announce earnings
Q3 results today: As for Trent, the fashion retailer posted a 124% jump in consolidated net profit to Rs 374.36 crore versus PAT of Rs 167 crore in the year-ago period.
Q3 results today: Nestle, Tata Consumer, Trent among 190 companies to announce earnings
On Tuesday, Nearly 160 companies will be announcing their December quarter earnings including the likes of Britannia Industries and FSN E-Commerce Ventures which operates Nykaa brand.
No change in 30% EBITDA margin guidance or long-term investment plan: Jonathan Hunt, Syngene
Syngene International, led by Jonathan Hunt, MD & CEO, remains committed to its long-term investment plans despite a guidance cut. The company experienced a slight softness in Q3 but expects it to be a temporary trend in the US biotech segment due to a slowdown in funding. The EBITDA margin guidance of around 30% remains unchanged, and the company is confident in its strong margin structure. As for capex guidance, the company adjusted it to $60 million for the year, with $40 million already invested and $20 million to be completed in the current quarter.
Syngene International Q3 Results: Net profit rises 2% YoY to Rs 112 crore, company revises revenue guidance
The rise in Q3 profit of Syngene International was led by dedicated centres and development and manufacturing services, even as discovery services business remained soft. The third quarter revenue from operations rose 9% YoY to Rs. 854 crore. The earnings before interest, tax, depreciation and ammortisation (EBITDA) rose 5% YoY to Rs. 261 crore in Q3FY24. The EBITDA margin dropped 100 basis points YoY to 30%.
US bank profits fall in choppy fourth quarter marked by special charges, falling lending margins
JPMorgan gained 0.9% and Citi fell 1.2%, while Bank of America fell 2.4% and Wells Fargo was down 2.3%. The banks combined set aside more than $8 billion to refill the Federal Deposit Insurance Corporation's deposit insurance fund (DIF), which took a $16 billion hit after Silicon Valley Bank and two other lenders failed last year.
'Survivor' guitarist Frankie Sullivan's home burglarized, watches worth $300,000 stolen
In the hills of the San Fernando Valley, Survivor band co-founder Frankie Sullivan faced a burglary as thieves target high-value homes. Law enforcement, linking the break-ins to a South American crew, advises enhanced security measures, echoing the recent woes of Keanu Reeves and others in the star-studded neighborhood.
Q2 results this week: Adani Ports, Tata Power, LIC, RVNL, M&M and others
Power Grid, Shree Cements, Trent, Zydus Lifesciences, Info Edge (India), Indian Railway Catering & Tourism Corporation, Cummins India, Alkem Laboratories, UNO Minda, Prestige Estates Projects, among others will release their Q2 earnings on November 7
Alphabet shares tank 9% to hit one-year low after cloud earnings miss
The company’s shares fell as much as 8.9% to $126.40 in New York, the biggest decline since October 2022. The shares had gained 57% so far this year through Tuesday’s close. The company posted $44 billion in search advertising, beating the average analyst projection for $43.2 billion.The company was pleased with its advertising revenue growth after a period of “historic volatility,” Porat said on an investor call after the results.
Revenue from ads, cloud help Google parent Alphabet beat Q2 topline, bottomline estimates
The tech giant’s revenue for the quarter stood at $74.6 billion, up 7% year-on-year (YoY) from $69.7 billion in the year-ago period.
Q1 IT preview: Weak macros signal dull quarter for IT, firms may narrow guidance
India's top four information technology firms are expected to post only a marginal increase sequentially in fiscal first-quarter revenue in constant currency, as weakness in the banking and financial services (BFS) sector and persistently high interest rates in Europe and the US will weigh on their results, analysts said.
TCS reports weaker than expected Q4 numbers; PhonePe chalks up another $100m from GA, more expected
Tata Consultancy Services (TCS) said its net profit for the final quarter of fiscal 2023 rose 15% on-year, but India’s largest software exporter pointed to macroeconomic concerns which may hurt the IT services firm. This and more in today’s ETtech Morning Dispatch.
TCS reports weaker than expected Q4 numbers; flags pain in North American market
Outgoing CEO & MD Rajesh Gopinathan told reporters on Wednesday that the fourth quarter numbers were “definitely weaker-than anticipated.”
Laurus Labs Q3 Results: Net profit rises 32% to Rs 203 crore
Dr. Satyanarayana Chava, founder and chief executive officer of Laurus Labs said the company is on path of diversification and strengthening non-ARV portfolio and building niche capabilities in specialty chemicals, animal health, agri-chemicals and biotech.
Q3 results this week: L&T, Bajaj Finserv, Sun Pharma, Tech Mahindra, Ashok Leyland and others
Results that will be out on January 30 include Larsen & Toubro, Bajaj Finserv, Tech Mahindra, Bharat Petroleum Corporation, Bajaj Holdings & Investment, GAIL, SRF, Punjab National Bank, REC, Laurus Labs, IIFL Finance, Trident, Exide Industries, Nippon Life India Asset Management, Mazagon Dock Shipbuilders, Welspun as well as Inox Leisure.
TCS posts 8.4% rise in Q2 net profit; IT firms may halve campus hiring this year
On a sequential basis, revenue was up 4.8% and profit was up 10%. This was also the first time the company crossed Rs 10,000 crore in quarterly net profit.
Corporate Radar: Titan to turn ex-dividend; TCS Q1 results; Havells India AGM & more
Tata Consultancy Services, MMTC, Kohinoor Foods, Shrenik, Brahmaputra Infrastructure, Morarka Finance and Spectrum Foods are among companies that will announce their quarterly earnings today.
Corporate Radar: LIC Q4 results, JSW Steel's dividend, Tilaknagar's referential issue & more
LIC, Sun Pharma, IRCTC, Jindal Steel & Power, Delhivery, Jubilant FoodWorks and Aurobindo Pharma are among the companies which will announce their quarterly earnings today.
Corporate Radar: Bonuses, dividends, Q4 results & more
Godrej Consumer Products, Dr. Reddy's Laboratories, Gland Pharma, Bosch, Ashok Leyland and HPCL are among companies which will announce their quarterly earnings today.
Gujarat Narmada Valley Fert zooms 9% as Q4 profit more than doubles
The company’s share price climbed to a high of Rs 824.40 as against Rs 757.20 at previous close on the BSE.
Load More